Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide for prevention of progression from acute pancreatitis to severe acute pancreatitis
ChiCTR-TRC-07000056Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of octreotide in acute pancreatitis (AP) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Mortality, APACHE II score and 1 more. Started Jan 2008; status: completed.
02
Drugs
octreotide
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on ChiCTR-TRC-07000056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-07000056.